Connective Tissue Disease and Pulmonary Arterial Hypertension: Multidisciplinary Coordination of Care to Optimize Outcomes Evaluation (i787-4)

Question Title

* 1. Please select the option that best describes your profession:

Rheumatologist

Pulmonologist

Internal Medicine

Fellow

PharmD/RPh

Other (please specify)

Question Title

* 2. How many years have you been in practice?

1-10

11-25

26-50

>50

Question Title

* 3. How many patients with CTD do you manage each week?

1-5

6-10

>11

I am not directly involved in patient care

Question Title

* 4. After participating in this activity, how confident are you in your ability to apply appropriate screening and diagnostic criteria to identify patients with CTDs who have PAH?

Very confident

Confident

Neutral

Little confidence

No confidence

Question Title

* 5. Which of the following best describes the impact of this activity on your performance?

I gained new strategies/skills/information I can apply to my area of practice

I need more information before I can change my practice

My practice is already consistent with the information presented

This activity will not change my practice

Question Title

* 6. How committed are you to making changes in your practice based on your participation in this activity?

Very committed

Committed

Neutral

Not committed

I do not plan to make changes

If not committed or do not plan to make changes, please indicate reason

Question Title

* 7. What barriers do you see to making changes in your practice?

Lack of knowledge regarding evidence-based strategies

Lack of convincing evidence to warrant change

Lack of time/resources to consider change

Insurance, reimbursement or legal issues

Conflicting guidelines or evidence

Patient compliance and/or patient resource barriers

Other

Question Title

* 8. Please rate your level of agreement by checking the appropriate rating.
5 = Strongly agree, 4 = Agree, 3 = Neutral, 2 = Disagree, 1 = Strongly disagree

After participating in today’s activity, I am now better able to:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Review the epidemiology and pathophysiology of CTD, and how it places patients at high risk for secondary PAH	Review the epidemiology and pathophysiology of CTD, and how it places patients at high risk for secondary PAH Strongly agree	Review the epidemiology and pathophysiology of CTD, and how it places patients at high risk for secondary PAH Agree	Review the epidemiology and pathophysiology of CTD, and how it places patients at high risk for secondary PAH Neutral	Review the epidemiology and pathophysiology of CTD, and how it places patients at high risk for secondary PAH Disagree	Review the epidemiology and pathophysiology of CTD, and how it places patients at high risk for secondary PAH Strongly disagree
Discuss how to use appropriate screening and diagnostic criteria to identify patients with CTDs who may have PAH	Discuss how to use appropriate screening and diagnostic criteria to identify patients with CTDs who may have PAH Strongly agree	Discuss how to use appropriate screening and diagnostic criteria to identify patients with CTDs who may have PAH Agree	Discuss how to use appropriate screening and diagnostic criteria to identify patients with CTDs who may have PAH Neutral	Discuss how to use appropriate screening and diagnostic criteria to identify patients with CTDs who may have PAH Disagree	Discuss how to use appropriate screening and diagnostic criteria to identify patients with CTDs who may have PAH Strongly disagree
Describe how to determine if patients should be referred for cardiac catheterization and definitively diagnose PAH	Describe how to determine if patients should be referred for cardiac catheterization and definitively diagnose PAH Strongly agree	Describe how to determine if patients should be referred for cardiac catheterization and definitively diagnose PAH Agree	Describe how to determine if patients should be referred for cardiac catheterization and definitively diagnose PAH Neutral	Describe how to determine if patients should be referred for cardiac catheterization and definitively diagnose PAH Disagree	Describe how to determine if patients should be referred for cardiac catheterization and definitively diagnose PAH Strongly disagree
Outline how to integrate guideline recommendations and efficacy and safety data of PAH pharmacotherapies for treatment of patients with CTD-PAH	Outline how to integrate guideline recommendations and efficacy and safety data of PAH pharmacotherapies for treatment of patients with CTD-PAH Strongly agree	Outline how to integrate guideline recommendations and efficacy and safety data of PAH pharmacotherapies for treatment of patients with CTD-PAH Agree	Outline how to integrate guideline recommendations and efficacy and safety data of PAH pharmacotherapies for treatment of patients with CTD-PAH Neutral	Outline how to integrate guideline recommendations and efficacy and safety data of PAH pharmacotherapies for treatment of patients with CTD-PAH Disagree	Outline how to integrate guideline recommendations and efficacy and safety data of PAH pharmacotherapies for treatment of patients with CTD-PAH Strongly disagree
Describe how to apply a collaborative approach across multidisciplinary experts to optimize outcomes for patients with CTD-PAH	Describe how to apply a collaborative approach across multidisciplinary experts to optimize outcomes for patients with CTD-PAH Strongly agree	Describe how to apply a collaborative approach across multidisciplinary experts to optimize outcomes for patients with CTD-PAH Agree	Describe how to apply a collaborative approach across multidisciplinary experts to optimize outcomes for patients with CTD-PAH Neutral	Describe how to apply a collaborative approach across multidisciplinary experts to optimize outcomes for patients with CTD-PAH Disagree	Describe how to apply a collaborative approach across multidisciplinary experts to optimize outcomes for patients with CTD-PAH Strongly disagree

Question Title

* 9. Please rate your level of agreement by checking the appropriate rating.
5 = Strongly agree, 4 = Agree, 3 = Neutral, 2 = Disagree, 1 = Strongly disagree

Flavia Castelino, MD

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Effectively presented the material	Effectively presented the material Strongly agree	Effectively presented the material Agree	Effectively presented the material Neutral	Effectively presented the material Disagree	Effectively presented the material Strongly disagree
Was knowledgeable	Was knowledgeable Strongly agree	Was knowledgeable Agree	Was knowledgeable Neutral	Was knowledgeable Disagree	Was knowledgeable Strongly disagree
Avoided commercial bias or influence	Avoided commercial bias or influence Strongly agree	Avoided commercial bias or influence Agree	Avoided commercial bias or influence Neutral	Avoided commercial bias or influence Disagree	Avoided commercial bias or influence Strongly disagree

Question Title

* 10. Please rate your level of agreement by checking the appropriate rating.
5 = Strongly agree, 4 = Agree, 3 = Neutral, 2 = Disagree, 1 = Strongly disagree

Nicholas S. Hill, MD

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Effectively presented the material	Effectively presented the material Strongly agree	Effectively presented the material Agree	Effectively presented the material Neutral	Effectively presented the material Disagree	Effectively presented the material Strongly disagree
Was knowledgeable	Was knowledgeable Strongly agree	Was knowledgeable Agree	Was knowledgeable Neutral	Was knowledgeable Disagree	Was knowledgeable Strongly disagree
Avoided commercial bias or influence	Avoided commercial bias or influence Strongly agree	Avoided commercial bias or influence Agree	Avoided commercial bias or influence Neutral	Avoided commercial bias or influence Disagree	Avoided commercial bias or influence Strongly disagree

Question Title

* 11. Please rate your level of agreement by checking the appropriate rating.
5 = Strongly agree, 4 = Agree, 3 = Neutral, 2 = Disagree, 1 = Strongly disagree

For this activity:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
The teaching and learning methods were effective	The teaching and learning methods were effective Strongly agree	The teaching and learning methods were effective Agree	The teaching and learning methods were effective Neutral	The teaching and learning methods were effective Disagree	The teaching and learning methods were effective Strongly disagree
The learning assessment used was appropriate	The learning assessment used was appropriate Strongly agree	The learning assessment used was appropriate Agree	The learning assessment used was appropriate Neutral	The learning assessment used was appropriate Disagree	The learning assessment used was appropriate Strongly disagree

Question Title

* 12. Please rate your level of agreement by checking the appropriate rating.
5 = Strongly agree, 4 = Agree, 3 = Neutral, 2 = Disagree, 1 = Strongly disagree

The content presented:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Enhanced my current knowledge base	Enhanced my current knowledge base Strongly agree	Enhanced my current knowledge base Agree	Enhanced my current knowledge base Neutral	Enhanced my current knowledge base Disagree	Enhanced my current knowledge base Strongly disagree
Addressed my most pressing questions	Addressed my most pressing questions Strongly agree	Addressed my most pressing questions Agree	Addressed my most pressing questions Neutral	Addressed my most pressing questions Disagree	Addressed my most pressing questions Strongly disagree
Promoted improvements or quality in health care	Promoted improvements or quality in health care Strongly agree	Promoted improvements or quality in health care Agree	Promoted improvements or quality in health care Neutral	Promoted improvements or quality in health care Disagree	Promoted improvements or quality in health care Strongly disagree
Was evidence-based and clinically relevant to current practice	Was evidence-based and clinically relevant to current practice Strongly agree	Was evidence-based and clinically relevant to current practice Agree	Was evidence-based and clinically relevant to current practice Neutral	Was evidence-based and clinically relevant to current practice Disagree	Was evidence-based and clinically relevant to current practice Strongly disagree

Question Title

* 13. As a result of your participation in this activity, what is the one change you are most likely to implement in your practice?

Question Title

* 14. Please list any clinical issues/problems within your scope of practice you would like to see addressed in future educational activities for this or related disease state:

Question Title

* 15. If you indicated that you perceived commercial bias or influence, please describe:

Question Title

* 16. Contact Information

First Name

Last Name

Telephone

Question Title

* 17. Pharmacists only

NABP#

Question Title

* 18. Pharmacists only

DOB

Question Title

* 1. Please select the option that best describes your profession:

Question Title

* 2. How many years have you been in practice?

Question Title

* 3. How many patients with CTD do you manage each week?

Question Title

* 4. After participating in this activity, how confident are you in your ability to apply appropriate screening and diagnostic criteria to identify patients with CTDs who have PAH?

Question Title

* 5. Which of the following best describes the impact of this activity on your performance?

Question Title

* 6. How committed are you to making changes in your practice based on your participation in this activity?

Question Title

* 7. What barriers do you see to making changes in your practice?

Question Title

* 8. Please rate your level of agreement by checking the appropriate rating. 5 = Strongly agree, 4 = Agree, 3 = Neutral, 2 = Disagree, 1 = Strongly disagreeAfter participating in today’s activity, I am now better able to:

Question Title

* 9. Please rate your level of agreement by checking the appropriate rating. 5 = Strongly agree, 4 = Agree, 3 = Neutral, 2 = Disagree, 1 = Strongly disagreeFlavia Castelino, MD

Question Title

* 10. Please rate your level of agreement by checking the appropriate rating. 5 = Strongly agree, 4 = Agree, 3 = Neutral, 2 = Disagree, 1 = Strongly disagreeNicholas S. Hill, MD

Question Title

* 11. Please rate your level of agreement by checking the appropriate rating. 5 = Strongly agree, 4 = Agree, 3 = Neutral, 2 = Disagree, 1 = Strongly disagreeFor this activity:

Question Title

* 12. Please rate your level of agreement by checking the appropriate rating. 5 = Strongly agree, 4 = Agree, 3 = Neutral, 2 = Disagree, 1 = Strongly disagreeThe content presented:

Question Title

* 13. As a result of your participation in this activity, what is the one change you are most likely to implement in your practice?

Question Title

* 14. Please list any clinical issues/problems within your scope of practice you would like to see addressed in future educational activities for this or related disease state:

Question Title

* 15. If you indicated that you perceived commercial bias or influence, please describe:

Question Title

* 16. Contact Information

Question Title

* 17. Pharmacists only

Question Title

* 18. Pharmacists only

* 8. Please rate your level of agreement by checking the appropriate rating.
5 = Strongly agree, 4 = Agree, 3 = Neutral, 2 = Disagree, 1 = Strongly disagree

After participating in today’s activity, I am now better able to:

* 9. Please rate your level of agreement by checking the appropriate rating.
5 = Strongly agree, 4 = Agree, 3 = Neutral, 2 = Disagree, 1 = Strongly disagree

Flavia Castelino, MD

* 10. Please rate your level of agreement by checking the appropriate rating.
5 = Strongly agree, 4 = Agree, 3 = Neutral, 2 = Disagree, 1 = Strongly disagree

Nicholas S. Hill, MD

* 11. Please rate your level of agreement by checking the appropriate rating.
5 = Strongly agree, 4 = Agree, 3 = Neutral, 2 = Disagree, 1 = Strongly disagree

For this activity:

* 12. Please rate your level of agreement by checking the appropriate rating.
5 = Strongly agree, 4 = Agree, 3 = Neutral, 2 = Disagree, 1 = Strongly disagree

The content presented: